Abacavir

Active ingredient description

Abacavir is a potent selective inhibitor of HIV-1 and HIV-2. The mechanism of action as to HIV, is the inhibition of the enzyme reverse transcriptase of HIV, an event that causes chain termination and stopping the replication cycle of the virus.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
J05AF06
Abacavir
J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF06

Medicines

Abacavir is the active ingredient of these drugs:

Drug
Countries
ABAMAT

South Africa

ABAMUNE

South Africa

ABAVAID

South Africa

BACAMUNE

South Africa

BAVIR

South Africa

HETACAV

South Africa

INVERTRON

South Africa

KAVIMUN PAED

South Africa

ZIAGEN

Australia Austria Canada Cyprus Finland

ZIAGENAVIR

Brazil

Abacavir is also found within below combination drugs:

ABAVILAM , AZADAR , BACATAC , COABLAM , DUMIVA , EPZICOM , HETERUAM , KIVALA , KIVEXA , MYLAMBA , RETRIKIL , TRIUMEQ , TRIZIVIR

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
ZIAGEN Oral solution
Summary of Product Characteristics (SPC)
ZIAGEN Film-coated tablet
Summary of Product Characteristics (SPC)

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

WR2TIP26VS - ABACAVIR

CAS registry number

136470-78-5 - abacavir

SNOMED-CT

387005008 - Abacavir (substance)

Next: Usage